GB0901411D0 - Treatment - Google Patents
TreatmentInfo
- Publication number
- GB0901411D0 GB0901411D0 GBGB0901411.9A GB0901411A GB0901411D0 GB 0901411 D0 GB0901411 D0 GB 0901411D0 GB 0901411 A GB0901411 A GB 0901411A GB 0901411 D0 GB0901411 D0 GB 0901411D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0901411.9A GB0901411D0 (en) | 2009-01-29 | 2009-01-29 | Treatment |
GB1001521A GB2467437A (en) | 2009-01-29 | 2010-01-29 | Phosphoantigen for use in the treatment of tularemia |
PCT/GB2010/000153 WO2010086617A2 (en) | 2009-01-29 | 2010-01-29 | Treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0901411.9A GB0901411D0 (en) | 2009-01-29 | 2009-01-29 | Treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0901411D0 true GB0901411D0 (en) | 2009-03-11 |
Family
ID=40469217
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0901411.9A Ceased GB0901411D0 (en) | 2009-01-29 | 2009-01-29 | Treatment |
GB1001521A Withdrawn GB2467437A (en) | 2009-01-29 | 2010-01-29 | Phosphoantigen for use in the treatment of tularemia |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1001521A Withdrawn GB2467437A (en) | 2009-01-29 | 2010-01-29 | Phosphoantigen for use in the treatment of tularemia |
Country Status (2)
Country | Link |
---|---|
GB (2) | GB0901411D0 (en) |
WO (1) | WO2010086617A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0212666D0 (en) | 2002-05-31 | 2002-07-10 | Secr Defence | Immunogenic sequences |
EP2040744B1 (en) | 2006-07-25 | 2016-03-09 | The Secretary of State for Defence | Live vaccine strains of francisella |
GB0906234D0 (en) | 2009-04-14 | 2009-05-20 | Secr Defence | Vaccine |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US153A (en) | 1837-03-25 | Peters | ||
US5666A (en) | 1848-07-11 | Machinery for sawing irregular shapes | ||
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4235877A (en) | 1979-06-27 | 1980-11-25 | Merck & Co., Inc. | Liposome particle containing viral or bacterial antigenic subunit |
SE8205892D0 (en) | 1982-10-18 | 1982-10-18 | Bror Morein | IMMUNOGENT MEMBRANE PROTEIN COMPLEX, SET FOR PREPARATION AND USE THEREOF |
US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
AU614755B2 (en) | 1987-06-05 | 1991-09-12 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Autocrine motility factors in cancer diagnosis and management |
US5278302A (en) | 1988-05-26 | 1994-01-11 | University Patents, Inc. | Polynucleotide phosphorodithioates |
US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US5308854A (en) | 1990-06-18 | 1994-05-03 | Merck & Co., Inc. | Inhibitors of HIV reverse transcriptase |
EP0468520A3 (en) | 1990-07-27 | 1992-07-01 | Mitsui Toatsu Chemicals, Inc. | Immunostimulatory remedies containing palindromic dna sequences |
US5187074A (en) | 1990-10-11 | 1993-02-16 | Merck & Co., Inc. | Method of hydroxylation with ATCC 55086 |
US5192668A (en) | 1990-10-11 | 1993-03-09 | Merck & Co., Inc. | Synthesis of protease inhibitor |
WO1993008184A1 (en) | 1991-10-23 | 1993-04-29 | Merck & Co., Inc. | Hiv protease inhibitors |
US5413999A (en) | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
SG49909A1 (en) | 1992-06-25 | 1998-06-15 | Smithkline Beecham Biolog | Vaccine composition containing adjuvants |
US5519021A (en) | 1992-08-07 | 1996-05-21 | Merck & Co., Inc. | Benzoxazinones as inhibitors of HIV reverse transcriptase |
DE69405551T3 (en) | 1993-03-23 | 2005-10-20 | Smithkline Beecham Biologicals S.A. | 3-0-DEAZYLATED MONOPHOSPHORYL LIPID A-CONTAINING VACCINE COMPOSITIONS |
WO1995010281A1 (en) | 1993-10-13 | 1995-04-20 | Merck & Co., Inc. | Combination therapy for hiv infection |
SI0729473T1 (en) | 1993-11-17 | 2001-02-28 | Om Pharma | Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use |
GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
WO1995026204A1 (en) | 1994-03-25 | 1995-10-05 | Isis Pharmaceuticals, Inc. | Immune stimulation by phosphorothioate oligonucleotide analogs |
US5476874A (en) | 1994-06-22 | 1995-12-19 | Merck & Co., Inc. | New HIV protease inhibitors |
GB9620795D0 (en) | 1996-10-05 | 1996-11-20 | Smithkline Beecham Plc | Vaccines |
UA56132C2 (en) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Vaccine composition (variants), method for stabilizing qs21 providing resistance against hydrolysis (variants), method for manufacturing vaccine |
US5846978A (en) | 1996-05-02 | 1998-12-08 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
US6764840B2 (en) | 1997-05-08 | 2004-07-20 | Corixa Corporation | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
US6303347B1 (en) | 1997-05-08 | 2001-10-16 | Corixa Corporation | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
GB9711990D0 (en) | 1997-06-11 | 1997-08-06 | Smithkline Beecham Biolog | Vaccine |
AU7924598A (en) | 1998-06-08 | 1999-12-30 | Sca Emballage France | Fast flattening packaging |
DK1091928T3 (en) | 1998-06-30 | 2007-07-23 | Om Pharma | Novel acylated pseudodipeptides, processes for their preparation and compositions containing them |
FR2782721B1 (en) | 1998-09-01 | 2000-11-03 | Inst Nat Sante Rech Med | NOVEL PHOSPHOHALOHYDRIN COMPOUNDS, MANUFACTURING METHOD AND APPLICATIONS |
US6558670B1 (en) | 1999-04-19 | 2003-05-06 | Smithkline Beechman Biologicals S.A. | Vaccine adjuvants |
IL145982A0 (en) | 1999-04-19 | 2002-07-25 | Smithkline Beecham Biolog | Vaccines |
WO2001046127A1 (en) | 1999-12-22 | 2001-06-28 | Om Pharma | Acyl pseudopeptides bearing a functionalised auxiliary spacer |
DK1408984T3 (en) * | 2001-07-20 | 2009-02-09 | Bioagency Ag | Organophosphorus compounds to activate gamma / delta T cells |
WO2005021708A2 (en) * | 2003-05-16 | 2005-03-10 | University Of Maryland Biotechnology Institute | Bisphosphonates for prophylaxis and therapy against bioterrorism agents |
WO2005102385A1 (en) * | 2004-04-26 | 2005-11-03 | Innate Pharma | Adjuvant composition and methods for its use |
WO2006067635A2 (en) * | 2004-12-20 | 2006-06-29 | Innate Pharma S.A. | USE OF Ϝδ T LYMPHOCYTE ACTIVATORS AS VACCINE ADJUVANT |
WO2006103568A2 (en) * | 2005-03-22 | 2006-10-05 | Innate Pharma | NEW CLASS OF Ϝδ T CELLS ACTIVATORS AND USE THEREOF |
WO2009131730A2 (en) * | 2008-01-31 | 2009-10-29 | University Of Iowa Research Foundation | IMMUNOGENIC COMPOSITIONS FOR ACTIVATING γδ T CELLS |
EP2123285A1 (en) * | 2008-05-21 | 2009-11-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Nucleosidic phosphoantigens for use in VGAMMA9DELTA2 T cell-mediated therapy |
-
2009
- 2009-01-29 GB GBGB0901411.9A patent/GB0901411D0/en not_active Ceased
-
2010
- 2010-01-29 WO PCT/GB2010/000153 patent/WO2010086617A2/en active Application Filing
- 2010-01-29 GB GB1001521A patent/GB2467437A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB201001521D0 (en) | 2010-03-17 |
WO2010086617A2 (en) | 2010-08-05 |
WO2010086617A3 (en) | 2010-09-16 |
GB2467437A (en) | 2010-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1175476A1 (en) | Cancer treatment | |
PL2652193T3 (en) | Treatment | |
IL213619A0 (en) | Treatment | |
GB0802116D0 (en) | Treatment | |
GB0920112D0 (en) | Treatment device | |
GB0822011D0 (en) | Treatment | |
IL217492A0 (en) | Treatment method | |
PL2437739T3 (en) | Glomerulonephritis treatment | |
IL214133A0 (en) | Skin treatment | |
GB0811992D0 (en) | Treatment | |
GB0900599D0 (en) | Treatment | |
GB201013898D0 (en) | Well treatment | |
GB201013573D0 (en) | Treatment | |
GB201001521D0 (en) | Treatment | |
GB0913968D0 (en) | Treatment | |
PL2263454T3 (en) | Treatment composition | |
GB0916997D0 (en) | Combination therapy | |
GB0820972D0 (en) | Treatment | |
GB0805912D0 (en) | Treatment | |
GB201014097D0 (en) | Treatment | |
GB0907973D0 (en) | Combination therapy | |
GB201001517D0 (en) | Treatment | |
GB0916542D0 (en) | Well treatment | |
GB0914581D0 (en) | Well treatment | |
GB0915045D0 (en) | Treatment system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |